{
    "2019-07-17": [
        [
            {
                "time": "",
                "original_text": "百白破等部分一类疫苗全国性断货 行业龙头公司望受关注",
                "features": {
                    "keywords": [
                        "百白破",
                        "疫苗",
                        "全国性断货",
                        "行业龙头"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "政策拔高疫苗行业壁垒 沃森生物等研发型企业受益",
                "features": {
                    "keywords": [
                        "政策",
                        "疫苗行业",
                        "壁垒",
                        "沃森生物",
                        "研发型企业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}